Insider Trades https://www.benzinga.com/views/taxonomy/term/62 en The Past Week's Notable Insider Buys: Amphenol, Aldeyra, Werewolf Therapeutics And More https://www.benzinga.com/news/21/05/21023794/the-past-weeks-notable-insider-buys-amphenol-aldeyra-werewolf-therapeutics-and-more <ul> <li><em>Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs.</em></li> <li><em>Once again, some insiders have taken advantage of initial public offerings.</em></li> <li><em>A couple of chief executive officers were among the insiders buying shares this past week.</em></li> </ul> <p>Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason &mdash; they believe the stock price will rise and they want to profit from it. So <a href="https://www.benzinga.com/news/insider-trades" target="_blank">insider buying</a> can be an encouraging signal for potential investors, particularly when there is uncertainty in the markets or the markets are near all-time highs.</p> <p>Note that, with the earnings reporting season still underway, many insiders are prohibited from buying or selling shares. Here are some of the most noteworthy insider purchases that were reported in the past week.</p> <p>A number of 10% owners of and directors at <strong>Werewolf Therapeutics Inc</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/howl#NASDAQ">HOWL</a>) bought into its initial public offer last week. The more than 4.84 million shares they bought for $16.00 apiece totaled over $77.98 million altogether. Shares of this cancer-focused biopharma company closed the week&#39;s trading at $14.25 apiece.</p> <p>The purchase of 1.20 million <strong>Aldeyra Therapeutics Inc</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aldx#NASDAQ">ALDX</a>) shares by a beneficial owner came before last week&#39;s first-quarter report. At the public offering price of $12.50 per share, those transactions totaled $15.00 million. ...</p><p><a href=https://www.benzinga.com/news/21/05/21023794/the-past-weeks-notable-insider-buys-amphenol-aldeyra-werewolf-therapeutics-and-more alt=The Past Week&#039;s Notable Insider Buys: Amphenol, Aldeyra, Werewolf Therapeutics And More>Full story available on Benzinga.com</a></p> AAT Aldeyra Therapeutics ALDX American Assets Trust ANAB AnaptysBio APAM APH Artisan Partners Asset Management Cyclerion Therapeutics CYCN eli lilly HOWL INTC Intel KDP Keurig Dr Pepper LLY News NOVA Penny Stocks Rockwell Automation ROK Sunnova Energy TRUP Trupanion VACC Vaccitech Werewolf Therapeutics Weyerhaeuser WY Small Cap Insider Trades INTC US4581401001 NOVA APH US0320951017 LLY US5324571083 ROK US7739031091 WY US9621661043 AAT US0240131047 APAM ALDX TRUP ANAB KDP CYCN VACC HOWL News Penny Stocks Small Cap Insider Trades Benzinga Sat, 08 May 2021 16:10:14 +0000 Nelson Hem 21023794 at https://www.benzinga.com Jeff Bezos Offloads $2.5B Amazon Shares, In First Major Sale For 2021 https://www.benzinga.com/news/21/05/20980269/jeff-bezos-offloads-2-5b-amazon-shares-in-first-major-sale-for-2021 <p><strong>Amazon.com Inc</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amzn#NASDAQ">AMZN</a>) CEO Jeff Bezos adopted a pre-arranged stock trading plan to sell&nbsp;739,032 shares of&nbsp;the e-commerce giant in the past few days, filings with the U.S. Securities and Exchange Commission revealed.</p> <p><strong>What Happened:</strong> According to company filings, Bezos unloaded shares in tranches under the prearranged 10b5-1 trading plan, selling about $2.5 billion worth of shares in his first big sale this ...</p><p><a href=https://www.benzinga.com/news/21/05/20980269/jeff-bezos-offloads-2-5b-amazon-shares-in-first-major-sale-for-2021 alt=Jeff Bezos Offloads $2.5B Amazon Shares, In First Major Sale For 2021>Full story available on Benzinga.com</a></p> AMZN e-commerce Jeff Bezos News Insider Trades Tech AMZN US0231351067 News Insider Trades Tech Benzinga Thu, 06 May 2021 02:32:06 +0000 Rachit Vats 20980269 at https://www.benzinga.com Last Week's Notable Insider Buys: Beacon Roofing, Chipotle, IPOs, Latham And More https://www.benzinga.com/news/21/05/20904903/last-weeks-notable-insider-buys-beacon-roofing-chipotle-ipos-latham-and-more <ul> <li><em>Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs.</em></li> <li><em>Once again, some insiders took advantage of recent public share offerings to add or bolster stakes.</em></li> <li><em>Again, biotechnology companies are well represented on this list.</em></li> </ul> <p>Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason -- they believe the stock price will rise and they want to profit from it. So <a href="https://www.benzinga.com/news/insider-trades" target="_blank">insider buying</a> can be an encouraging signal for potential investors, particularly when there is uncertainty in the markets or the markets are near all-time highs.</p> <p>Note that, with the earnings reporting season still underway, many insiders are prohibited from buying or selling shares. Here are some of the most noteworthy insider purchases that were reported in the past week.</p> <p>The combined 3.52 million or so <strong>Impel Neuropharma Inc</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/impl#NASDAQ">IMPL</a>) shares that five beneficial owners purchased had an initial public offering price of $15.00 per share. These transactions cost them more than $52.87 million. The stock has traded as high as $15.89 a share since the offering but ended the week at $15.20.</p> <p><strong>Rain Therapeutics Inc</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rain#NASDAQ">RAIN</a>) saw two beneficial owners and a former 10% owner buy into the IPO. The more than 2.02 million shares of this oncology company acquired altogether, ...</p><p><a href=https://www.benzinga.com/news/21/05/20904903/last-weeks-notable-insider-buys-beacon-roofing-chipotle-ipos-latham-and-more alt=Last Week&#039;s Notable Insider Buys: Beacon Roofing, Chipotle, IPOs, Latham And More>Full story available on Benzinga.com</a></p> AMEH ANAB AnaptysBio Apollo Medical Arcus Biosciences ASB Associated Banc beacon roofing supply BECN Capstar Financial Chipotle Mexican Grill CLI CMG CSTR heartland express HTLD Impel NeuroPharma IMPL KNBE KnowBe4 Latham Mack Cali Realty News Penny Stocks RAIN Rain Therapeutics RCUS SWIM TCBI TELL Tellurian Texas Capital Bancshares Texas Pacific Land TPL Small Cap Insider Trades ASB BECN US0736851090 CSTR US19259P3001 HTLD US4223471040 SWIM TCBI US88224Q1076 CLI US5544891048 CMG US1696561059 TPL US8826101086 AMEH ANAB RAIN TELL RCUS KNBE IMPL News Penny Stocks Small Cap Insider Trades Benzinga Sun, 02 May 2021 12:05:23 +0000 Nelson Hem 20904903 at https://www.benzinga.com Last Week's Notable Insider Buys: AppLovin, Bed Bath And Beyond, TuSimple And More https://www.benzinga.com/news/21/04/20780767/last-weeks-notable-insider-buys-applovin-bed-bath-and-beyond-tusimple-and-more <ul> <li><em>Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs.</em></li> <li><em>Once again, some insiders took advantage of recent public share offerings to add or bolster stakes.</em></li> <li><em>Industrials, real estate investment trusts and a retailer saw insider purchases, and a beneficial owner returned to the buy window again.</em></li> </ul> <p>Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason -- they believe the stock price will rise and they want to profit from it. So <a href="https://www.benzinga.com/news/insider-trades" target="_blank">insider buying</a> can be an encouraging signal for potential investors, particularly when there is uncertainty in the markets or the markets are near all-time highs.</p> <p>Note that, with the new earnings reporting season underway, many insiders are prohibited from buying or selling shares. Here are some of the most noteworthy insider purchases that were reported in the past week.</p> <p><strong>Neuropace Inc</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/npce#NASDAQ">NPCE</a>) saw two beneficial owners and two other insiders buy into last week&#39;s initial public offering. The almost 875,600 shares of this medical device maker acquired at $17&nbsp;apiece added up to more than $14.88 million. The stock ended the week trading at $25.44 per share.</p> <p>New Jersey-based real estate investment trust (REIT) <strong>Mack Cali Realty Corp</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cli#NYSE">CLI</a>) had a director indirectly pick up 240,000 shares recently at prices ...</p><p><a href=https://www.benzinga.com/news/21/04/20780767/last-weeks-notable-insider-buys-applovin-bed-bath-and-beyond-tusimple-and-more alt=Last Week&#039;s Notable Insider Buys: AppLovin, Bed Bath And Beyond, TuSimple And More>Full story available on Benzinga.com</a></p> APP Applovin ARK Invest BBBY Bed Bath & Beyond Cathie Wood CLI GBX greenbrier HC2 HCHC Mack Cali Realty Molecular Templates MTEM Neuropace New Residential Investment News NPCE NRZ Penny Stocks RCII Rent-A-Center SNDX Syndax Pharmaceuticals Texas Pacific Land TPL TSP TuSimple York Water YORW Small Cap Insider Trades APP US0238501003 BBBY US0758961009 RCII US76009N1000 YORW US9871841089 CLI US5544891048 GBX US3936571013 TPL US8826101086 TSP NRZ SNDX HCHC MTEM NPCE News Penny Stocks Small Cap Insider Trades Benzinga Sun, 25 Apr 2021 12:30:15 +0000 Nelson Hem 20780767 at https://www.benzinga.com Moderna's Flagship Venture Firm Cashed $1.4B From Stock Sale In Two Months: Forbes https://www.benzinga.com/general/biotech/21/04/20751211/modernas-flagship-venture-firm-cashed-1-4b-from-stock-sale-in-two-months-forbes <ul> <li>Almost a decade ago, Flagship Pioneering, a VC fund run and majority-owned by&nbsp;<strong>Moderna Inc&rsquo;s</strong>&nbsp;(NASDAQ:&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/stock/mrna#NASDAQ" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">MRNA</a>) chairman and co-founder, Noubar Afeyan, poured cash into the company, even when Moderna had faced some early setbacks.</li> <li>Over the last 13 months, since the World Health Organization declared a pandemic, Flagship has sold off Moderna shares worth more than $1.4 billion,&nbsp;<a class="editor-rtfLink" href="https://www.forbes.com/sites/giacomotognini/2021/04/22/vc-firm-of-moderna-chairman-dumped-14-billion-of-stock-in-two-months/?sh=384018123caa" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">as reported by Forbes</a>.</li> <li>The most recent sales came in late February and March this year when two Flagship funds, ...</li></ul><p><a href=https://www.benzinga.com/general/biotech/21/04/20751211/modernas-flagship-venture-firm-cashed-1-4b-from-stock-sale-in-two-months-forbes alt=Moderna&#039;s Flagship Venture Firm Cashed $1.4B From Stock Sale In Two Months: Forbes>Full story available on Benzinga.com</a></p> Biotech Briefs MRNA News Health Care Insider Trades General MRNA US56804Q1022 News Biotech Health Care Insider Trades General Benzinga Thu, 22 Apr 2021 17:53:06 +0000 Vandana Singh 20751211 at https://www.benzinga.com Last Week's Notable Insider Buys Included Evergy, StoneMor, Tattooed Chef And More https://www.benzinga.com/news/21/04/20671863/last-weeks-notable-insider-buys-included-evergy-stonemor-tattooed-chef-and-more <ul> <li><em>Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs.</em></li> <li><em>Even with a new earnings season underway, insiders were still making notable share purchases.</em></li> <li><em>Some of those insiders made return trips to the buy window, and a couple of chief executives were among the buyers too.</em></li> </ul> <p>Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason -- they believe the stock price will rise and they want to profit from it. So <a href="https://www.benzinga.com/news/insider-trades" target="_blank">insider buying</a> can be an encouraging signal for potential investors, particularly when there is uncertainty in the markets or the markets are near all-time highs.</p> <p>Note that, with the new earnings reporting season underway, many insiders are prohibited from buying or selling shares. Here are some of the most noteworthy insider purchases that were reported in the past week.</p> <p><strong>Evergy Inc</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/evrg#NYSE">EVRG</a>) saw a director indirectly acquire more than $113.17 million worth of shares mid-week. That was nearly 2.27 million shares of this Kansas City-based electric utility purchased at $49.87 apiece. The stock popped 4% last week and was last seen trading at $63.29 per share.</p> <p>San Diego-based <strong>Reneo Pharmaceuticals Inc</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rphm#NASDAQ">RPHM</a>) had two directors and two beneficial owners pick up more than 1.73 million shares altogether at the initial public offering price of $15&nbsp;apiece. ...</p><p><a href=https://www.benzinga.com/news/21/04/20671863/last-weeks-notable-insider-buys-included-evergy-stonemor-tattooed-chef-and-more alt=Last Week&#039;s Notable Insider Buys Included Evergy, StoneMor, Tattooed Chef And More>Full story available on Benzinga.com</a></p> Evergy EVRG GMS GMS Landec Liquidia LNDC LQDA MACK Merrimack Pharmaceuticals Molecular Templates MTEM NantHealth News NH Nuvation Bio NUVB Old Republic International ORI Penny Stocks Reneo Pharmaceuticals RPHM STON StoneMor Tattooed Chef Texas Pacific Land TPL TTCF York Water YORW Small Cap Insider Trades LNDC US5147661046 STON US86183Q1004 YORW US9871841089 GMS ORI US6802231042 TPL US8826101086 MACK NH MTEM EVRG LQDA TTCF NUVB RPHM News Penny Stocks Small Cap Insider Trades Benzinga Sun, 18 Apr 2021 12:52:54 +0000 Nelson Hem 20671863 at https://www.benzinga.com Insider Buys Landec Stock https://www.benzinga.com/news/21/04/20643676/insider-buys-landec-stock <p>&nbsp;</p> <p>Shares of <strong>Landec Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNDC#NASDAQ">LNDC</a>) moved higher by 5% from the previous closing price. Wynnefield Partners Small Cap Value Lp I filed a Form 4 with the SEC on Thursday, April 15. The insider bought 165,564 shares at $10.02 on Monday, Apr 12, and bought 2,508 shares at $10.09 on Tuesday, Apr 13. . After the transactions, the executive&#39;s stake in Landec Inc. movedto 1,743,034 shares.</p> <h2>The Importance of Insider Transactions</h2> <p>While transactions from an insider shouldn&#39;t be used as the sole item to make an investment or trading decision, an insider buying ...</p><p><a href=https://www.benzinga.com/news/21/04/20643676/insider-buys-landec-stock alt=Insider Buys Landec Stock>Full story available on Benzinga.com</a></p> BZI-IT LNDC News Insider Trades Intraday Update Markets LNDC US5147661046 News Insider Trades Intraday Update Markets Benzinga Thu, 15 Apr 2021 15:15:12 +0000 Benzinga Insights 20643676 at https://www.benzinga.com Richard Branson Sheds Virgin Galactic Stake By $150M https://www.benzinga.com/news/21/04/20633609/richard-branson-sheds-virgin-galactic-stake-by-150m <p>British billionaire Sir Richard Branson sold nearly $150 million worth shares of his space tourism company <strong>Virgin Galactic Holdings Inc</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spce#NYSE">SPCE</a>) over the course of three days, as per a regulatory filing.</p> <p><strong>What Happened:</strong> Branson sold a total of 5,584,000 shares at an average price of $26.818&nbsp;between Monday and Wednesday. The stock sale comes a month after the company&rsquo;s Chairman Chamath Palihapitiya sold the last of his personal stake in Virgin Galactic, <a href="https://www.benzinga.com/news/21/03/20031856/palihapitiya-sells-off-virgin-galactic-stake-freeing-up-more-cash" style="text-decoration:none">freeing</a> up another $21 million in cash.&nbsp;&nbsp;</p> <p>After the sale, Branson owns 56.8 million shares in Virgin Galactic.</p> <p>"Virgin intends to use the net proceeds from this sale to support its portfolio of global leisure, holiday and travel businesses that continue to be affected ...</p><p><a href=https://www.benzinga.com/news/21/04/20633609/richard-branson-sheds-virgin-galactic-stake-by-150m alt=Richard Branson Sheds Virgin Galactic Stake By $150M>Full story available on Benzinga.com</a></p> AMZN Chamath Palihapitiya Elon Musk News Richard Branson space tourism SpaceX SPCE Insider Trades Tech AMZN US0231351067 SPCE News Insider Trades Tech Benzinga Thu, 15 Apr 2021 08:10:20 +0000 Rachit Vats 20633609 at https://www.benzinga.com GameStop CEO Forfeits $98M Worth Of Shares For Not Meeting 'Stated Performance Target' Amid Rumors Of Ousting https://www.benzinga.com/news/21/04/20633230/gamestop-ceo-forfeits-98m-worth-of-shares-for-not-meeting-stated-performance-target-amid-rumors-of-o <p><strong>GameStop Corp. </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gme#NYSE">GME</a>) Chief Executive Officer George Sherman, who is facing a potential ouster, has forfeited shares worth almost $98 million after he failed to meet his &ldquo;stated performance target.&rdquo;</p> <p><strong>What Happened:</strong> Sherman has forfeited more than 587,000 GameStop shares that were originally granted to him in April 2019, <a href="https://www.sec.gov/Archives/edgar/data/0001326380/000132638021000045/xslF345X03/wf-form4_161843420829711.xml">according</a> to a regulatory filing. Based on Wednesday&rsquo;s closing stock price of $166.53, the shares are worth about $98 million.</p> <p>Another regulatory filing <a href="https://news.gamestop.com/static-files/9d0fbda1-377c-417a-9da4-d51608b2450a">showed</a> that Chris Homeister, GameStop&#39;s chief merchandising officer, forfeited more than 119,000 shares for his failure to meet performance targets.</p> <p><em>See Also: <a ...</em></p><p><a href=https://www.benzinga.com/news/21/04/20633230/gamestop-ceo-forfeits-98m-worth-of-shares-for-not-meeting-stated-performance-target-amid-rumors-of-o alt=GameStop CEO Forfeits $98M Worth Of Shares For Not Meeting &#039;Stated Performance Target&#039; Amid Rumors Of Ousting>Full story available on Benzinga.com</a></p> AMZN CHWY George Sherman GME Meme Stocks News Ryan Cohen Short Squeeze wallstreetbets Insider Trades Tech AMZN US0231351067 GME US36467W1099 CHWY News Insider Trades Tech Benzinga Thu, 15 Apr 2021 04:14:02 +0000 Madhukumar Warrier 20633230 at https://www.benzinga.com Insider Buys Greenwich LifeSciences Shares https://www.benzinga.com/news/21/04/20622255/insider-buys-greenwich-lifesciences-shares <p>&nbsp;</p> <p><strong>Greenwich LifeSciences Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLSI#NASDAQ">GLSI</a>) was trading 4.4% higher from the previous closing price. CEO Patel Snehal filed a Form 4 with the SEC on Wednesday, April 14. The insider bought 2,700 shares at an average price of $36.98. After the transaction, the executive&#39;s stake in Greenwich LifeSciences Inc. moved to 1,189,539 shares.</p> <h2>Why Insider Transactions Are Important?</h2> <p>Insider transactions shouldn&#39;t be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision.</p> <p>When an insider buys stock after an important ...</p><p><a href=https://www.benzinga.com/news/21/04/20622255/insider-buys-greenwich-lifesciences-shares alt=Insider Buys Greenwich LifeSciences Shares>Full story available on Benzinga.com</a></p> BZI-IT GLSI News Insider Trades Intraday Update Markets GLSI News Insider Trades Intraday Update Markets Benzinga Wed, 14 Apr 2021 17:19:03 +0000 Benzinga Insights 20622255 at https://www.benzinga.com Insider Sells Royalty Pharma's Shares https://www.benzinga.com/news/21/04/20622256/insider-sells-royalty-pharmas-shares <p>&nbsp;</p> <p>A Form 4 filing filed with the SEC on Wednesday, April 14 showed that EVP Reddoch James F. sold 359 shares of <strong>Royalty Pharma Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPRX#NASDAQ">RPRX</a>) at an average price of $42.32. The transaction moved the executive&#39;s stake in Royalty Pharma Inc. to 255,714 shares.&nbsp;Royalty Pharma was trading 2.8% higher from the previous closing price.</p> <h2>The Importance of Insider Transactions</h2> <p>Insider transactions shouldn&#39;t be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision.</p> <p>When an insider buys stock ...</p><p><a href=https://www.benzinga.com/news/21/04/20622256/insider-sells-royalty-pharmas-shares alt=Insider Sells Royalty Pharma&#039;s Shares>Full story available on Benzinga.com</a></p> BZI-IT News RPRX Insider Trades Intraday Update Markets RPRX News Insider Trades Intraday Update Markets Benzinga Wed, 14 Apr 2021 17:17:23 +0000 Benzinga Insights 20622256 at https://www.benzinga.com Insider Sells Nuveen Floating Rate Income Fund Stock https://www.benzinga.com/news/21/04/20622258/insider-sells-nuveen-floating-rate-income-fund-stock <p>&nbsp;</p> <p>A Form 4 filing filed with the SEC on Wednesday, April 14 showed that Saba Capital Management, L.P. sold 27,179 shares of <strong>Nuveen Floating Rate Income Fund</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JFR#NYSE">JFR</a>)&nbsp;at $9.72 on Monday, Apr 12, and sold 159,060 shares at $9.70 on Tuesday, Apr 13.The transaction moved the executive&#39;s stake in Nuveen Floating Rate Inc Inc. to 6,301,239 shares.&nbsp;Shares of Nuveen Floating Rate Income Fund &nbsp;moved higher by 0.2% from the previous closing price.</p> <h2>The Importance of Insider Transactions</h2> <p>Insider transactions shouldn&#39;t be used primarily to make an investing ...</p><p><a href=https://www.benzinga.com/news/21/04/20622258/insider-sells-nuveen-floating-rate-income-fund-stock alt=Insider Sells Nuveen Floating Rate Income Fund Stock>Full story available on Benzinga.com</a></p> BZI-IT JFR News Insider Trades Intraday Update Markets JFR US67072T1088 News Insider Trades Intraday Update Markets Benzinga Wed, 14 Apr 2021 17:16:00 +0000 Benzinga Insights 20622258 at https://www.benzinga.com Insider Sells Nuveen Floating Rate Income Opportunity Fund Shares https://www.benzinga.com/news/21/04/20622262/insider-sells-nuveen-floating-rate-income-opportunity-fund-shares <p>&nbsp;</p> <p>Saba Capital Management, L.P. filed a Form 4 with the SEC on Wednesday, April 14. The insider sold 11,958 shares of <strong>Nuveen Floating Rate Income Opportunity Fund</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JRO#NYSE">JRO</a>) at $9.57 on Monday, Apr 12, and sold 28,507 shares at $9.55 on Tuesday, Apr 13. . After the transactions, the executive&#39;s stake in Nuveen Floating Rate Inc Inc. movedto 4,457,397 shares.&nbsp;Shares of Nuveen Floating Rate Income Opportunity Fund moved higher by 0.1% from the previous closing price.</p> <h2>Why Insider Transactions Are Important?</h2> <p>While transactions from an insider shouldn&#39;t be used as the sole item to ...</p><p><a href=https://www.benzinga.com/news/21/04/20622262/insider-sells-nuveen-floating-rate-income-opportunity-fund-shares alt=Insider Sells Nuveen Floating Rate Income Opportunity Fund Shares>Full story available on Benzinga.com</a></p> BZI-IT JRO News Insider Trades Intraday Update Markets JRO US6706EN1001 News Insider Trades Intraday Update Markets Benzinga Wed, 14 Apr 2021 17:14:35 +0000 Benzinga Insights 20622262 at https://www.benzinga.com Insider Sells Nuveen Short Duration Shares https://www.benzinga.com/news/21/04/20622264/insider-sells-nuveen-short-duration-shares <p>&nbsp;</p> <p>A Form 4 filing filed with the SEC on Wednesday, April 14 showed that Saba Capital Management, L.P. sold 16,401 shares of&nbsp;<strong>Nuveen Short Duration Credit Opportunities Fund</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JSD#NYSE">JSD</a>)&nbsp;at $14.27 on Monday, Apr 12, and sold 1,435 shares at $14.31 on Tuesday, Apr 13.The transaction moved the executive&#39;s stake in Nuveen Short Duration Inc. to 1,143,967 shares.&nbsp;Nuveen Short Duration Credit Opportunities Fund was trading 0.1% higher from the previous closing price.</p> <h2>The Importance of Insider Transactions</h2> <p>While transactions from an insider shouldn&#39;t be used as the sole item to make an investment or trading ...</p><p><a href=https://www.benzinga.com/news/21/04/20622264/insider-sells-nuveen-short-duration-shares alt=Insider Sells Nuveen Short Duration Shares>Full story available on Benzinga.com</a></p> BZI-IT JSD News Insider Trades Intraday Update Markets JSD News Insider Trades Intraday Update Markets Benzinga Wed, 14 Apr 2021 17:12:46 +0000 Benzinga Insights 20622264 at https://www.benzinga.com Insider Sells Voya Prime Rate Trust Shares https://www.benzinga.com/news/21/04/20622265/insider-sells-voya-prime-rate-trust-shares <p>&nbsp;</p> <p>A Form 4 filing filed with the SEC on Wednesday, April 14 showed that Saba Capital Management, L.P. sold 52,930 shares of <strong>Voya Prime Rate Trust Inc</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPR#NYSE">PPR</a>)&nbsp;at $4.65 on Monday, Apr 12, and sold 56,342 shares at $4.65 on Tuesday, Apr 13.The transaction moved the executive&#39;s stake in Voya Prime Rate Trust Inc. to 27,105,550 shares.&nbsp;Voya Prime Rate Trust Inc &nbsp;was trading flat from the previous closing price.</p> <h2>Why Insider Transactions Are Important?</h2> <p>Insider transactions shouldn&#39;t be used primarily to make an investing decision, however an insider transaction can be an important ...</p><p><a href=https://www.benzinga.com/news/21/04/20622265/insider-sells-voya-prime-rate-trust-shares alt=Insider Sells Voya Prime Rate Trust Shares>Full story available on Benzinga.com</a></p> BZI-IT News PPR Insider Trades Intraday Update Markets PPR US44977W1062 News Insider Trades Intraday Update Markets Benzinga Wed, 14 Apr 2021 17:11:27 +0000 Benzinga Insights 20622265 at https://www.benzinga.com